BRISTOL-MYERS SQUIBB NAMES STEPHEN BEAR TO HEAD WORLDWIDE OTC DRUG BUSINESS
This article was originally published in The Tan Sheet
Executive Summary
BRISTOL-MYERS SQUIBB NAMES STEPHEN BEAR TO HEAD WORLDWIDE OTC DRUG BUSINESS as part of a management reorganization of the company's international consumer products businesses. Formerly executive VP of Bristol-Myers Squibb's U.S. Consumer Products Group, Bear has been named president of Worldwide Consumer Medicines with responsibility for "the global activities" of the Bristol-Myers Products Division and the company's consumer businesses in Japan, the company said. Bear, 42, will report directly to Bristol-Myers Squibb President and CEO Charles Heimbold.